SERA · Sera Prognostics Inc
United States · RS rating 43 · As of 2026-11-03
| Price | 1.93 USD |
|---|---|
| 1-day change | -3.0% |
| RS rating (overall / 1M / 3M / 12M) | 43 / 48 / 59 / 25 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 19 / 24 / 29 |
| Industry group (rank) | Medical-Services (63) |
| EPS growth Q/Q | +0.0% |
| Sales growth Q/Q | -37.5% |
| Distance from 52-week high | +47.7% |
| Market cap (USD) | $83.0M |